:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Iskandar Idris
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Diabetes, Obesity and Metabolism Now
Online Access:	https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.88
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
by: Iskandar Idris
Published: (2024)

Epigenetic changes shown to cause type 2 diabetes
by: Iskandar Idris
Published: (2024)

Appropriate timing of exercise for adults with obesity including those with type 2 diabetes
by: Iskandar Idris
Published: (2024)

Can diet and exercise intervention prevent type 2 diabetes in individuals with a high genetic risk?
by: Iskandar Idris
Published: (2024)

Extension study from DIRECT showed ongoing remission rate from type 2 diabetes in some patient following very low calorie diet at 5 years
by: Iskandar Idris
Published: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
by: Iskandar Idris
Published: (2024)

Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk
by: Iskandar Idris
Published: (2024)

Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
by: Iskandar Idris
Published: (2024)

Precision medicine approach to detect obese people who are at high risk of developing diabetes
by: Iskandar Idris
Published: (2024)

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
by: Iskandar Idris
Published: (2024)

The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
by: Iskandar Idris
Published: (2024)

Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
by: Iskandar Idris
Published: (2024)

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
by: Iskandar Idris
Published: (2024)

Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea
by: Iskandar Idris
Published: (2024)

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
by: Iskandar Idris
Published: (2024)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
by: Iskandar Idris
Published: (2024)

Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target?
by: Iskandar Idris
Published: (2024)

Increasing excess to weight loss injection shown to save thousands of lives a year
by: Iskandar Idris
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
by: Iskandar Idris, et al.
Published: (2025)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
by: Jing Shen, et al.
Published: (2025)

Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial
by: Karen Elkind‐Hirsch, et al.
Published: (2025)

What is the impact of an advanced hybrid closed‐loop system on weight control among people with type 1 diabetes?
by: Sarah Koning, et al.
Published: (2025)

Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
by: Lauren V. Turner, et al.
Published: (2024)

CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
by: Roland H. Stimson, et al.
Published: (2025)

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
by: Wanling Lu, et al.
Published: (2025)

Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
by: Satish K. Garg, et al.
Published: (2024)

Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
by: Abdullah M. Alguwaihes, et al.
Published: (2025)

Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
by: Heejun Son, et al.
Published: (2025)

A novel glucose beta‐hydroxybutyrate combination improves hypoglycaemia recovery and patient‐reported outcomes in type 1 diabetes
by: D. Russell‐Jones, et al.
Published: (2025)

Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications
by: Julia I. P. van Heck, et al.
Published: (2024)

Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial
by: Emmanuel Ssemmondo, et al.
Published: (2024)

Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
by: Nathaniel Foo, et al.
Published: (2025)